A Risk Sciences International news item posted on September 21, 2023 and last updated on October 23, 2025

Working with the College of Physicians and Surgeons of Alberta, Risk Sciences International conducted a wide-ranging review of aging and cognitive decline, with specific focus on aging physicians and fitness to practice.  The publication in Aging & Mental Health documents domains of cognition that decline with older age, concerns with relying on physician self-reported competency, challenges with cognitive screening in older physicians, and a general data gap linking cognitive levels and fitness to practice.

Full article: Should we screen aging physicians for cognitive decline? (tandfonline.com)

Experts related to this news item

Natalia (Natasha) Shilnikova

Senior Health Risk Analyst

Dr. Natalia (Natasha) Shilnikova is a Senior Health Risk Analyst at Risk Sciences International (RSI), where she has contributed since 2011 to some of the organization’s most analytically demanding and policy-relevant projects. With a background in medicine and a PhD...
Read More about Natalia (Natasha) Shilnikova

Franco Momoli

Vice-President Chemical and Product Safety

Dr. Franco Momoli joined Risk Sciences International (RSI) in 2019 and currently serves as Vice-President, Chemical and Product Safety. In this role, he leads a multidisciplinary team of epidemiologists, risk assessors, toxicologists, and biostatisticians in conducting human health risk assessments...
Read More about Franco Momoli

Jennifer Go

Risk Analyst, Epidemiologist

Jennifer joined RSI in August 2017 as a Risk Analyst with a specialization in epidemiology. To date, she has contributed to numerous literature reviews on various topics, including: Potential adverse health effects of asbestos in drinking water; Age-related cognitive decline...
Read More about Jennifer Go

Daniel Krewski

Chief Risk Scientist

Dr. Daniel Krewski is Chief Risk Scientist and co-founder of Risk Sciences International (RSI), a firm established in 2006 to bring evidence-based, multidisciplinary expertise to the challenge of understanding, managing, and communicating risk. As RSI’s inaugural CEO and long-time scientific...
Read More about Daniel Krewski

More RSI News

IAI climate change report

April 12, 2022

The International Aluminium Institute (IAI) recently commissioned Climate Risk Institute (CRI) and Risk Sciences International (RSI) to produce a series of informational tools evaluating and…

Quinolones and risk of acute liver failure

April 12, 2022

Quinolones, are a class of widely used and popular powerful antibiotics with broad coverage. RSI investigators, Mohamed Taher, Franco Momoli, Donald Mattison and Daniel Krewski,…

RSI launches Global Risk Census

March 1, 2022

Risk Sciences International has launched The Global Risk Census. The goal of the Census is to provide insights into important risks that need to be…

US FDA FAERS and quinolones

June 22, 2021

Some case reports on Quinolones, a potent and globally popular group of antibiotics that are used to treat a wide range of infections, have raised…